Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants.
about
Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infantsEarly (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsInhaled nitric oxide for respiratory failure in preterm infantsEarly (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsInhaled nitric oxide for respiratory failure in preterm infantsInhaled nitric oxide for respiratory failure in preterm infantsEarly postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infantsInhaled nitric oxide in preterm infants: An updated meta-analysisInhaled nitric oxide for respiratory failure in preterm infants.Inhaled nitric oxide in preterm infants: a systematic review and individual patient data meta-analysis.Postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function.A risk-benefit assessment of drugs used for neonatal chronic lung disease.Inhaled nitric oxide treatment for preterm infants with hypoxic respiratory failure.Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trialsSafety and efficacy of nitric oxide in chronic lung diseaseCurrent pharmacologic approaches for prevention and treatment of bronchopulmonary dysplasia.Can nitric oxide-based therapy prevent bronchopulmonary dysplasia?Inhaled nitric oxide in term and preterm infants.Is nitric oxide effective in preterm infants?Guidelines for Rational and Cost-Effective Use of iNO Therapy in Term and Preterm InfantsInhaled nitric oxide and neuroprotection in preterm infants.Inhaled nitric oxide in the neonate.Inhaled nitric oxide applications in paediatric practice.Our paper 20 years later: Inhaled nitric oxide for the acute respiratory distress syndrome--discovery, current understanding, and focussed targets of future applications.Outcomes of inhaled nitric oxide in preterm neonates - a five-year experience in a tertiary neonatal centre.Early Use of Inhaled Nitric Oxide in Preterm Infants: Is there a Rationale for Selective Approach?Early inhaled nitric oxide improves oxidative balance in very preterm infants.Efficacy of glucocorticoids, vitamin A and caffeine therapies for neonatal mortality in preterm infants: a network meta-analysis.Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.Inhaled nitric oxide: effects on cerebral growth and injury in a baboon model of premature delivery.Inhaled nitric oxide in infants >1500 g and <34 weeks gestation with severe respiratory failure.
P2860
Q24194676-C827CB49-EC1D-4348-A745-65A74D197AADQ24194710-C82AAB6C-B19B-42A2-859B-B430C281F468Q24235781-C001B24A-2A07-406E-9507-5A2675B22129Q24240398-0CDDBBEB-F302-4B52-A2F3-284384DBEAD2Q24243892-4D043010-EBB0-4DA0-8B22-96E43B6327F7Q24244692-19359290-8EDA-4F1D-8111-C65CF1C12DF3Q24250213-B057BF43-B7F1-4C51-8038-45F34C26C770Q28078175-BEBCB9BC-4DCB-4002-85C0-3F5952E31940Q30239834-1B349AC1-B694-4D61-B037-C9971450CAFFQ33544922-535FCD98-EDC3-457E-8AE7-C3B2963077B4Q33888778-70195AC8-782B-41C5-B94B-68F922217BABQ33929574-8E43D1E3-CDF8-4D25-8084-D32B049D6ED1Q34004449-DFB135C0-AACF-41B0-845B-63C36014B906Q34022590-501BD9C0-7D6D-4960-952A-2811A39F213CQ35291458-FED6BE71-C930-43EA-96AB-928B40FC7A50Q35675944-02CA21E7-3198-42DA-8422-A786BB33B2D6Q36220974-F0C33DC5-4212-4CF5-AD42-8E6B01B7761FQ36453821-B6F95E62-AB48-4F45-9E86-F74ED96A17A1Q36915837-A86B8902-D701-4F2A-B726-4D77B3F08352Q37094554-124111C9-683B-4413-ACA5-C1BB32DCBF0DQ37280686-74300E55-47DF-4FFA-88D5-EF7043369824Q37462138-178E71D8-9F8F-4FD2-8E95-D714388395EFQ37988497-8E02E322-EE46-40BB-8D7B-701C399CBBEEQ38247234-C2F5A7DC-E736-4F90-8CC6-80A989AF6406Q38511604-C4096B29-C15D-4D07-B07F-3522441B2EBDQ38821344-3E4F2EB5-591F-4A17-9E22-EECD5EE935BAQ45299611-83E55CA5-CC0A-4968-8B34-6D87784470AFQ47139802-83890FA0-2A9F-44E9-AEFD-8D0106301C11Q47235829-AB99216D-7887-4557-96BE-C9085FE96D8EQ47235844-E9F23C31-6E63-4147-83FD-2F8E6533C3DBQ48214414-DE54F49A-9765-48F7-B94D-E9006B25E42CQ51988662-42B5CBF7-5ED1-4C88-94A1-CDBB2ADD6903
P2860
Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants.
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Open randomised controlled tri ...... in high risk preterm infants.
@ast
Open randomised controlled tri ...... in high risk preterm infants.
@en
type
label
Open randomised controlled tri ...... in high risk preterm infants.
@ast
Open randomised controlled tri ...... in high risk preterm infants.
@en
prefLabel
Open randomised controlled tri ...... in high risk preterm infants.
@ast
Open randomised controlled tri ...... in high risk preterm infants.
@en
P2093
P2860
P356
P1476
Open randomised controlled tri ...... in high risk preterm infants.
@en
P2093
P2860
P304
P356
10.1136/FN.77.3.F185
P577
1997-11-01T00:00:00Z